These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 8895780)

  • 1. Group A streptococcal adhesion. All of the theories are correct.
    Hasty DL; Courtney HS
    Adv Exp Med Biol; 1996; 408():81-94. PubMed ID: 8895780
    [No Abstract]   [Full Text] [Related]  

  • 2. Passive protection of mice against group A streptococcal pharyngeal infection by lipoteichoic acid.
    Dale JB; Baird RW; Courtney HS; Hasty DL; Bronze MS
    J Infect Dis; 1994 Feb; 169(2):319-23. PubMed ID: 8106764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salivary specific antibodies in relation to adhesion of Streptococcus pyogenes to pharyngeal cells of patients with rheumatic fever and rheumatic heart disease.
    Kumar KS; Ganguly NK; Chandrashekher Y; Anand IS; Wahi PL
    Adv Exp Med Biol; 1995; 371A():677-9. PubMed ID: 8526017
    [No Abstract]   [Full Text] [Related]  

  • 4. Pathogenesis of group A streptococci in mice and efficacy of locally administered streptococcal vaccines.
    Bronze MS; McKinsey DS; Beachey EH; Dale JB
    Trans Assoc Am Physicians; 1988; 101():88-92. PubMed ID: 3077732
    [No Abstract]   [Full Text] [Related]  

  • 5. [Further study of the prevention of streptococcal infections in experiments on monkeys].
    Keller V; Dzhikidze EK; Voskanian NA; Kiunemund O; Knol' G
    Vestn Akad Med Nauk SSSR; 1986; (3):66-8. PubMed ID: 3518270
    [No Abstract]   [Full Text] [Related]  

  • 6. Host cell specific adhesins of group A streptococci.
    Courtney HS; Dale JB; Hasty DL
    Adv Exp Med Biol; 1997; 418():605-6. PubMed ID: 9331724
    [No Abstract]   [Full Text] [Related]  

  • 7. Pathogenesis of rheumatic fever: a review.
    Rotta J
    Ann Trop Paediatr; 1983 Mar; 3(1):1-8. PubMed ID: 6191642
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunity to group a streptococcal M proteins: forging a single-edged sword.
    Madoff LC
    Clin Infect Dis; 2005 Oct; 41(8):1123-4. PubMed ID: 16163630
    [No Abstract]   [Full Text] [Related]  

  • 9. The fibronectin binding domain of the Sfb protein adhesin of Streptococcus pyogenes occurs in many group A streptococci and does not cross-react with heart myosin.
    Valentin-Weigand P; Talay SR; Kaufhold A; Timmis KN; Chhatwal GS
    Microb Pathog; 1994 Aug; 17(2):111-20. PubMed ID: 7861955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal immunisation of mice with a streptococcal peptide-based vaccine.
    Relf W; Hayman W; Russell-Jones G; Good M
    Adv Exp Med Biol; 1997; 418():859-61. PubMed ID: 9331788
    [No Abstract]   [Full Text] [Related]  

  • 11. Group A streptococcal antigens and vaccine potential.
    Kehoe MA
    Vaccine; 1991 Nov; 9(11):797-806. PubMed ID: 1722063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Primary prevention of rheumatism: the status and outlook (vaccine)].
    Rotta Y
    Ter Arkh; 1985; 57(11):97-100. PubMed ID: 3909476
    [No Abstract]   [Full Text] [Related]  

  • 13. Distribution and antigenicity of fibronectin binding proteins (SfbI and SfbII) of Streptococcus pyogenes clinical isolates from the northern territory, Australia.
    Goodfellow AM; Hibble M; Talay SR; Kreikemeyer B; Currie BJ; Sriprakash KS; Chhatwal GS
    J Clin Microbiol; 2000 Jan; 38(1):389-92. PubMed ID: 10618121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The molecular basis for the localization of bacterial infections.
    Christensen GD; Beachey EH
    Adv Intern Med; 1984; 30():79-112. PubMed ID: 6152109
    [No Abstract]   [Full Text] [Related]  

  • 15. Group A and group B streptococcal vaccine development. A round table presentation.
    Dale JB; Cleary PP; Fischetti VA; Kasper DL; Musser JM; Zabriskie JB
    Adv Exp Med Biol; 1997; 418():863-8. PubMed ID: 9331789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The quest for GAS vaccine.
    Pandey M; Good MF
    Oncotarget; 2015 Oct; 6(33):34063-4. PubMed ID: 26485764
    [No Abstract]   [Full Text] [Related]  

  • 17. Prospects for a group A streptococcal vaccine.
    McMillan DJ; Chhatwal GS
    Curr Opin Mol Ther; 2005 Feb; 7(1):11-6. PubMed ID: 15732524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoglobulins inhibit adherence and internalization of Streptococcus pyogenes to human pharyngeal cells.
    Fluckiger U; Fischetti VA
    Adv Exp Med Biol; 1997; 418():909-11. PubMed ID: 9331796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to the conserved region of the M protein and a streptococcal superantigen cooperatively resolve toxic shock-like syndrome in HLA-humanized mice.
    Pandey M; Calcutt A; Ozberk V; Chen Z; Croxen M; Powell J; Langshaw E; Mills JL; Jen FE; McCluskey J; Robson J; Tyrrell GJ; Good MF
    Sci Adv; 2019 Sep; 5(9):eaax3013. PubMed ID: 31517054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demonstration of protection in mice from a lethal challenge of three M serotypes of Streptococcus pyogenes using an M-negative vaccine.
    Chappell JD; Stuart JG
    Vaccine; 1993; 11(6):643-8. PubMed ID: 8322487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.